Orbimed Advisors - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 189 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 0.96 and the average weighting 0.3%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2021$74,183,000
-38.5%
2,183,143
-33.8%
0.82%
-33.3%
Q2 2021$120,714,000
+95.0%
3,297,301
+138.8%
1.22%
+110.9%
Q1 2021$61,920,000
-3.6%
1,380,900
+22.7%
0.58%
+3.0%
Q4 2020$64,244,000
+11.2%
1,125,7000.0%0.56%
-22.6%
Q3 2020$57,748,000
-14.1%
1,125,7000.0%0.73%
-23.3%
Q2 2020$67,227,000
+41.1%
1,125,700
-2.8%
0.95%
+18.1%
Q1 2020$47,658,000
-49.4%
1,157,600
-23.5%
0.80%
-40.4%
Q4 2019$94,242,000
+12.8%
1,514,171
-38.5%
1.34%
-15.1%
Q3 2019$83,512,000
+2.4%
2,460,571
-32.0%
1.58%
+25.4%
Q2 2019$81,590,000
-2.8%
3,618,1710.0%1.26%
-2.8%
Q1 2019$83,978,000
+63.8%
3,618,171
+48.2%
1.30%
+37.1%
Q4 2018$51,262,000
-32.2%
2,442,200
+25.0%
0.95%
+4.1%
Q3 2018$75,640,000
-4.2%
1,953,500
-2.6%
0.91%
-3.2%
Q2 2018$78,924,000
+156.9%
2,005,700
+30.8%
0.94%
+147.0%
Q1 2018$30,719,000
+15.2%
1,532,900
+30.3%
0.38%
+13.1%
Q4 2017$26,662,000
+256.1%
1,176,070
+198.3%
0.34%
+368.1%
Q3 2017$7,487,000394,2700.07%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q4 2020
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,209,571$15,385,74319.76%
Redmile Group, LLC 4,475,384$56,926,8842.71%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,897,606$87,737,5481.93%
Parkman Healthcare Partners LLC 597,403$7,598,9661.39%
Ghost Tree Capital, LLC 325,000$4,134,0001.36%
BRAIDWELL LP 3,336,221$42,436,7311.34%
AlphaCentric Advisors LLC 132,000$1,679,0400.95%
ARMISTICE CAPITAL, LLC 4,612,000$58,664,6400.90%
Sunesis Advisors, LLC 96,299$1,224,9230.87%
EcoR1 Capital, LLC 993,000$12,630,9600.43%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders